Evaluations of extracellular PH within in vivo tumors using acidocest MRI

Liu Qi Chen, Christine M. Howison, Justin J. Jeffery, Ian F. Robey, Phillip H Kuo, Mark "Marty" Pagel

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Purpose: A practical, noninvasive method is needed to measure the extracellular pH (pHe) within in vivo tumors to longitudinally monitor tumor acidosis. We have optimized a biomedical imaging method, termed acidoCEST MRI, to provide noninvasive assessments of tumor pHe in preclinical models of mammary carcinoma.

Methods: A CEST-FISP MRI method was optimized to detect the chemical exchange saturation transfer (CEST) of two amide protons of a clinically approved CT contrast agent, iopromide. The ratio of the two CEST effects was used to measure pH. Routes of administration of iopromide were evaluated to ensure sufficient delivery of the agent to the tumor. The optimized acido- CEST MRI method was then used to evaluate the change in tumor pHe following alkalinizing bicarbonate treatment.

Results: The acidoCEST MRI protocol measured pH between 6.2 and 7.2 pH units. Greater delivery of iopromide was shown to improve the precision of the measurement of tumor pHe, but the agent did not influence the tumor pHe. AcidoCEST MRI was used to longitudinally monitor the effect of bicarbonate treatment on the pHe of tumors and bladders. Conclusion: This study demonstrates that an optimized acido- CEST MRI method is a practical, noninvasive method for assessing changes in tumor acidosis.

Original languageEnglish (US)
Pages (from-to)1408-1417
Number of pages10
JournalMagnetic Resonance in Medicine
Volume72
Issue number5
DOIs
StatePublished - Nov 1 2014

Fingerprint

iopromide
Neoplasms
Bicarbonates
Acidosis
Urinary Bladder Neoplasms
Amides
Contrast Media
Protons
Breast Neoplasms

Keywords

  • Bicarbonate treatment
  • CEST MRI
  • CEST-FISP
  • Iopromide
  • Tumor pH

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Evaluations of extracellular PH within in vivo tumors using acidocest MRI. / Chen, Liu Qi; Howison, Christine M.; Jeffery, Justin J.; Robey, Ian F.; Kuo, Phillip H; Pagel, Mark "Marty".

In: Magnetic Resonance in Medicine, Vol. 72, No. 5, 01.11.2014, p. 1408-1417.

Research output: Contribution to journalArticle

Chen, Liu Qi ; Howison, Christine M. ; Jeffery, Justin J. ; Robey, Ian F. ; Kuo, Phillip H ; Pagel, Mark "Marty". / Evaluations of extracellular PH within in vivo tumors using acidocest MRI. In: Magnetic Resonance in Medicine. 2014 ; Vol. 72, No. 5. pp. 1408-1417.
@article{ad37639aa2bf47edb9cde5617a62129a,
title = "Evaluations of extracellular PH within in vivo tumors using acidocest MRI",
abstract = "Purpose: A practical, noninvasive method is needed to measure the extracellular pH (pHe) within in vivo tumors to longitudinally monitor tumor acidosis. We have optimized a biomedical imaging method, termed acidoCEST MRI, to provide noninvasive assessments of tumor pHe in preclinical models of mammary carcinoma.Methods: A CEST-FISP MRI method was optimized to detect the chemical exchange saturation transfer (CEST) of two amide protons of a clinically approved CT contrast agent, iopromide. The ratio of the two CEST effects was used to measure pH. Routes of administration of iopromide were evaluated to ensure sufficient delivery of the agent to the tumor. The optimized acido- CEST MRI method was then used to evaluate the change in tumor pHe following alkalinizing bicarbonate treatment.Results: The acidoCEST MRI protocol measured pH between 6.2 and 7.2 pH units. Greater delivery of iopromide was shown to improve the precision of the measurement of tumor pHe, but the agent did not influence the tumor pHe. AcidoCEST MRI was used to longitudinally monitor the effect of bicarbonate treatment on the pHe of tumors and bladders. Conclusion: This study demonstrates that an optimized acido- CEST MRI method is a practical, noninvasive method for assessing changes in tumor acidosis.",
keywords = "Bicarbonate treatment, CEST MRI, CEST-FISP, Iopromide, Tumor pH",
author = "Chen, {Liu Qi} and Howison, {Christine M.} and Jeffery, {Justin J.} and Robey, {Ian F.} and Kuo, {Phillip H} and Pagel, {Mark {"}Marty{"}}",
year = "2014",
month = "11",
day = "1",
doi = "10.1002/mrm.25053",
language = "English (US)",
volume = "72",
pages = "1408--1417",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Evaluations of extracellular PH within in vivo tumors using acidocest MRI

AU - Chen, Liu Qi

AU - Howison, Christine M.

AU - Jeffery, Justin J.

AU - Robey, Ian F.

AU - Kuo, Phillip H

AU - Pagel, Mark "Marty"

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Purpose: A practical, noninvasive method is needed to measure the extracellular pH (pHe) within in vivo tumors to longitudinally monitor tumor acidosis. We have optimized a biomedical imaging method, termed acidoCEST MRI, to provide noninvasive assessments of tumor pHe in preclinical models of mammary carcinoma.Methods: A CEST-FISP MRI method was optimized to detect the chemical exchange saturation transfer (CEST) of two amide protons of a clinically approved CT contrast agent, iopromide. The ratio of the two CEST effects was used to measure pH. Routes of administration of iopromide were evaluated to ensure sufficient delivery of the agent to the tumor. The optimized acido- CEST MRI method was then used to evaluate the change in tumor pHe following alkalinizing bicarbonate treatment.Results: The acidoCEST MRI protocol measured pH between 6.2 and 7.2 pH units. Greater delivery of iopromide was shown to improve the precision of the measurement of tumor pHe, but the agent did not influence the tumor pHe. AcidoCEST MRI was used to longitudinally monitor the effect of bicarbonate treatment on the pHe of tumors and bladders. Conclusion: This study demonstrates that an optimized acido- CEST MRI method is a practical, noninvasive method for assessing changes in tumor acidosis.

AB - Purpose: A practical, noninvasive method is needed to measure the extracellular pH (pHe) within in vivo tumors to longitudinally monitor tumor acidosis. We have optimized a biomedical imaging method, termed acidoCEST MRI, to provide noninvasive assessments of tumor pHe in preclinical models of mammary carcinoma.Methods: A CEST-FISP MRI method was optimized to detect the chemical exchange saturation transfer (CEST) of two amide protons of a clinically approved CT contrast agent, iopromide. The ratio of the two CEST effects was used to measure pH. Routes of administration of iopromide were evaluated to ensure sufficient delivery of the agent to the tumor. The optimized acido- CEST MRI method was then used to evaluate the change in tumor pHe following alkalinizing bicarbonate treatment.Results: The acidoCEST MRI protocol measured pH between 6.2 and 7.2 pH units. Greater delivery of iopromide was shown to improve the precision of the measurement of tumor pHe, but the agent did not influence the tumor pHe. AcidoCEST MRI was used to longitudinally monitor the effect of bicarbonate treatment on the pHe of tumors and bladders. Conclusion: This study demonstrates that an optimized acido- CEST MRI method is a practical, noninvasive method for assessing changes in tumor acidosis.

KW - Bicarbonate treatment

KW - CEST MRI

KW - CEST-FISP

KW - Iopromide

KW - Tumor pH

UR - http://www.scopus.com/inward/record.url?scp=84907957267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907957267&partnerID=8YFLogxK

U2 - 10.1002/mrm.25053

DO - 10.1002/mrm.25053

M3 - Article

C2 - 24281951

AN - SCOPUS:84907957267

VL - 72

SP - 1408

EP - 1417

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 5

ER -